HomeNewsBusinessEconomyPM Modi likely to meet heads of PSBs, NBFCs this week to take stock of credit availability

PM Modi likely to meet heads of PSBs, NBFCs this week to take stock of credit availability

Given the economic situation at present, banks are taking a conservative approach in retail lending, as uncertainty looms large over retail segment loans as the private sector grapples with pay cuts and job losses.

July 28, 2020 / 16:09 IST
Story continues below Advertisement
Narendra Modi, Prime minister of India | Though almost all of India’s Prime Ministers have come from the nearly 80% of the population that is Hindu, only Modi has governed as if no one else matters,” writes Karl Vick, Time editor. (Image: Reuters)
Narendra Modi, Prime minister of India | Though almost all of India’s Prime Ministers have come from the nearly 80% of the population that is Hindu, only Modi has governed as if no one else matters,” writes Karl Vick, Time editor. (Image: Reuters)

Prime Minister Modi is expected to hold a meeting with stakeholders from the financial sector in the next few days, a senior government official told Moneycontrol.

"It (the meeting) will happen soon. Expectedly this week itself, in the next few days," the official said.

Story continues below Advertisement

The meeting is expected to be attended by heads of public sector banks and non-banking financial companies (NBFCs).

"Yes, the prime minister is expected to chair the meeting. Officials from finance ministry would also attend it. It will be a kind of stock taking of credit flow and how much of the liquidity benefits have been passed on," the official said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show